COPT Defense Properties (NYSE:CDP) Plans $0.32 Quarterly Dividend

COPT Defense Properties (NYSE:CDP) announced a quarterly dividend on Thursday, August 13th. Investors of record on Wednesday, September 30th will be given a dividend of 0.32 per share on Thursday, October 15th. This represents a c) annualized dividend and a yield of 3.4%. The ex-dividend date of this dividend is Wednesday, September 30th.

COPT Defense Properties has raised its dividend by an average of 0.0%per year over the last three years.

COPT Defense Properties Stock Performance

NYSE:CDP opened at $37.26 on Friday. The company has a quick ratio of 2.89, a current ratio of 2.89 and a debt-to-equity ratio of 1.64. The firm’s fifty day simple moving average is $36.24 and its 200 day simple moving average is $33.31. The stock has a market cap of $4.23 billion, a P/E ratio of 25.88 and a beta of 0.76. COPT Defense Properties has a twelve month low of $27.06 and a twelve month high of $38.90.

COPT Defense Properties (NYSE:CDP) last issued its quarterly earnings data on Monday, July 27th. The company reported $0.40 EPS for the quarter, topping the consensus estimate of $0.33 by $0.07. COPT Defense Properties had a net margin of 20.94% and a return on equity of 10.48%. The business had revenue of $197.39 million during the quarter, compared to analyst estimates of $189.36 million. During the same period in the prior year, the business earned $0.34 EPS. COPT Defense Properties has set its FY 2026 guidance at 1.390-1.430 EPS and its Q3 2026 guidance at 0.370-0.390 EPS. As a group, research analysts predict that COPT Defense Properties will post 2.78 EPS for the current year.

About COPT Defense Properties

COPT Defense Properties (NYSE: CDP) is a real estate investment trust organized to own, lease and manage healthcare and life science facilities serving the United States federal government, with a particular focus on Department of Defense and Veterans Affairs tenants. The company was formed in 2016 through a spin-off from Corporate Office Properties Trust, enabling it to concentrate exclusively on medical office buildings and specialized research facilities situated on or near military and federal research campuses.

The company’s portfolio comprises purpose-built, Class A medical office and outpatient specialty clinics, as well as life science laboratories.